Global Newsroom

^{_{CSL Behring Patient Zahra Khan, living with hereditary angioedema}}

Global Newsroom

How Can We Help You?

Media Resources
Media Contacts

Recent News Releases

Featuring releases from CSL, CSL Behring, CSL Seqirus and CSL Vifor.

Apr 17, 2024

Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build “Australia’s next CSL”

Australia’s newest biotech incubator Jumar Bioincubator has officially opened its doors and revealed the first 16 innovative early-stage ventures to take up residency in its much-awaited Melbourne-based facility at an event officiated by Lord Mayor, Sally Capp AO.

Recent News Releases

Email Alerts

CSL Behring

Jan 16, 2024

Harris Poll Survey Finds People Receiving Treatment for CIDP Are Interested in Exploring More Convenient Treatment Options

Findings show that convenience of treatment and flexibility of administration, such as at-home treatment options, are of high importance to patients KING OF PRUSSIA, Pa., Jan. 16, 2024...

Recent News Releases

Email Alerts

CSL Seqirus

Mar 7, 2024

CSL Adopts Regional/National Public Health Timetable on the Removal of B/Yamagata Seasonal Influenza Virus Strain

March 7, 2024 During the latter part of 2023 and following notification by the World Health Organization that B/Yamagata lineage viruses have not been confirmed as detected in circulation since...

Recent News Releases

Email Alerts

CSL Vifor

Apr 24, 2024

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

First non-immunosuppressive therapy for the treatment of IgA Nephropathy (IgAN) approved in Europe Conditional marketing authorization is based on statistically significant and clinically...